Celldex Therapeutics, Inc. Additional Paid in Capital, Common Stock
Celldex Therapeutics, Inc. (CLDX) had Additional Paid in Capital, Common Stock of $2.68 billion as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-08-06
- 2026-06-30: Additional Paid in Capital, Common Stock $2.68B.
- 2026-03-31: Additional Paid in Capital, Common Stock $2.35B.
- 2025-12-31: Additional Paid in Capital, Common Stock $2.34B.
- 2025-09-30: Additional Paid in Capital, Common Stock $2.33B.
| Period end | Additional Paid in Capital, Common Stock | Additional Paid in Capital, Common Stock as first filed |
|---|---|---|
| 2026-06-30 | $2.68B 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $2.35B 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.34B 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $2.33B 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $2.32B 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $2.31B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.30B 10-K · filed 2026-02-25 | |
| 2024-09-30 | $2.29B 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $2.28B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $2.27B 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $1.82B 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.60B 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $1.59B 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $1.59B 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.58B 10-K · filed 2024-02-26 | |
| 2022-09-30 | $1.57B 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $1.57B 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $1.56B 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $1.56B 10-K · filed 2023-02-28 | |
| 2021-09-30 | $1.56B 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $1.28B 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1.28B 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.28B 10-K · filed 2022-02-28 | |
| 2020-09-30 | $1.28B 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $1.27B 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.11B 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $1.10B 10-K · filed 2021-03-29 | |
| 2019-09-30 | $1.10B 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $1.10B 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $1.09B 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $1.08B 10-K · filed 2020-03-26 | |
| 2018-09-30 | $1.08B 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $1.07B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $1.06B 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $1.05B 10-K · filed 2019-03-07 | $1.05B 10-K · filed 2018-03-07 |
| 2017-09-30 | $1.03B 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $1.01B 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $998.90M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $982.25M 10-K · filed 2018-03-07 | |
| 2016-09-30 | $901.56M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $889.47M 10-Q · filed 2016-08-08 | |
| 2016-03-31 | $882.88M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $878.65M 10-K · filed 2017-03-14 | |
| 2015-09-30 | $874.24M 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $869.63M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $866.77M 10-Q · filed 2015-04-29 | |
| 2014-12-31 | $672.74M 10-K/A · filed 2016-02-25 | |
| 2014-09-30 | $668.60M 10-Q · filed 2014-11-05 | |
| 2014-06-30 | $666.33M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $664.67M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $662.72M 10-K · filed 2015-02-24 | |
| 2013-09-30 | $477.60M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $474.94M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $473.63M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $357.09M 10-K · filed 2014-03-03 | |
| 2012-09-30 | $335.50M 10-Q · filed 2012-11-02 | |
| 2012-06-30 | $324.06M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $323.59M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $271.03M 10-K · filed 2013-03-08 | |
| 2011-09-30 | $270.25M 10-Q · filed 2011-11-03 | |
| 2011-06-30 | $269.69M 10-Q · filed 2011-08-04 | |
| 2010-12-31 | $232.68M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |